Senior Software Engineer, Infrastructure & Platform
In sede · London (Regno Unito) · Senior · Tempo pieno
Vuoi altre offerte come questa?
Crea il tuo profilo gratuito su PyHires: vedrai quanto sei compatibile con ogni offerta e riceverai ogni settimana un'email con quelle più adatte a te.
Panoramica
- Modalità di lavoro
- In sede
- Sede
- London (Regno Unito)
- Tipo di contratto
- Tempo pieno
- Seniority
- Senior
- Lingue
- Inglese
- Aperta a candidati da
- Tutta Europa (UE ed extra-UE)
- Azienda
- Boltz
- Pubblicata
- 19 nov 2026
Il ruolo
Boltz, an MIT spin-out and public benefit company, builds open molecular modelling models (Boltz-1, Boltz-2, BoltzGen) used by 100,000+ scientists, and Boltz Lab, the platform where partners design and rank candidate molecules. As Software Engineer on Infrastructure & Platform you will build and run the systems between the models and the scientists: fast, reliable training and serving on GPUs, and the APIs, services, data pipelines and storage behind Boltz Lab. This is not an ML research role.
What you'll do
- Profile and optimise training and inference, reduce memory and compute overhead and scale workloads across GPUs and cloud
- Design and scale APIs and backend services
- Evolve data ingestion and storage pipelines
- Own the cloud and container infrastructure everything runs on
What you bring
- 6+ years building and operating backend, infrastructure or ML systems in production
- Strong software engineering fundamentals and well-tested, maintainable systems
- Strong Python, with PyTorch and the scientific Python ecosystem
- Hands-on experience with cloud and containerised environments such as AWS, Docker and Kubernetes
What they offer
- One of the most talent-dense teams in the field
- A highly competitive salary with meaningful equity in a public benefit company
- 25 days of annual leave plus bank holidays
Requisiti
Basata su:Python
Indispensabili
- AWS
- Docker
- Kubernetes
- PyTorch
Chi è Boltz
Boltz is a public benefit company building AI-powered molecular modelling tools to make biology programmable and accelerate drug discovery. It began as an MIT spin-out: its open models Boltz-1, Boltz-2 and BoltzGen are used by more than 100,000 scientists and in programmes at every Top 20 pharma, and its commercial platform Boltz Lab runs its latest models and design agents for partners.
Stack
- Python
- AWS
- Docker
- Kubernetes
- PyTorch
Azienda
Boltz
Regno Unito